Reynolds Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Reynolds Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,100	Closed	-$452K	–	239
2015 Q1	$452K	Sell	7,100 -200	-3%	-$13.6K	0.39%	83
2014 Q4	$451K	Buy	7,300 +100	+1%	+$4.93K	0.38%	91
2014 Q3	$280K	Buy	7,200 +800	+13%	+$28.4K	0.27%	137
2014 Q2	$220K	Sell	6,400 -1,700	-21%	-$53.5K	0.15%	293
2014 Q1	$350K	Buy	8,100 +900	+13%	+$43.6K	0.23%	179
2013 Q4	$287K	Sell	7,200 -2,700	-27%	-$96.2K	0.16%	248
2013 Q3	$372K	Buy	+9,900	New	+$296K	0.24%	137

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Reynolds Capital Management's IONS Position: Q2 2015 in Review

Reynolds Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2015, closing a stake of 7,100 shares — an estimated $452K sold.

Reynolds Capital Management first reported a position in IONS in Q3 2013 and held it in 7 quarters. The position peaked at $452K in Q1 2015. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

Reynolds Capital Management reported no remaining Ionis Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Reynolds Capital Management sold 7,100 Ionis Pharmaceuticals shares in Q2 2015, an estimated $452K.
Reynolds Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 7 quarters.
Reynolds Capital Management's Ionis Pharmaceuticals position peaked at $452K in Q1 2015.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on Reynolds Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.